NCT07023055View on ClinicalTrials.gov

Serum TAM Receptor Tyrosine Kinase Ligands in Acute Pancreatitis

CompletedOBSERVATIONAL
Enrollment

896

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
Acute Pancreatic NecrosisAcute Pancreatitis (AP)
Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

The first affiliated Hospital of Nanjing Medical University, Jiangsu Province

UNKNOWN

lead

Peking Union Medical College Hospital

OTHER

NCT07023055 - Serum TAM Receptor Tyrosine Kinase Ligands in Acute Pancreatitis | Biotech Hunter | Biotech Hunter